Around 40 per cent of children worldwide suffer from anaemia because they do not consume enough iron. Research by ETH Zurich has now shown that iron deficiency also reduces the protective effect of vaccinations.
It is well known that vaccines are less effective in low-income countries than in the Global North. Until now, it was not clear why this was the case. In a study involving children in Kenya, the iron status and the levels of antibodies against antigens from the administered vaccines were measured in blood samples from 303 children during the first 18 months of life. More than half of the children were already suffering from anaemia by the age of 10 weeks, and by the age of 24 weeks, more than 90 per cent of the children had low haemoglobin levels and a low red blood cell count. The risk of having no protective antibodies against pneumococci and other pathogens in the blood was more than twice as high in these children as in children with normal haemoglobin levels.
In a second study, the scientists administered a daily dose of a micronutrient powder to 127 infants aged just over six months for four months. The children whose powder also contained iron not only had higher levels of measles antibodies in their blood at 12 months of age, but their antibodies were also better at recognising the pathogens.
References:
ETH Zurich: https://ethz.ch/de/news-und-veranstaltungen/eth-news/news/2020/07/iron-deficiency-reduces-vaccine-effectiveness.html
Iron Deficiency Anaemia at the Time of Vaccination Predicts a Reduced Vaccine Response and Iron Supplementation at the Time of Vaccination Increases the Humoral Vaccine Response: A Birth Cohort Study and a Randomised Trial Follow-up Study in Kenyan Infants. Front. Immunol. 11:1313.
https://doi.org/10.3389/fimmu.2020.01313